HYBRID EVENT: You can participate in person at Tokyo, Japan from your home or work.
Bile duct cancer

Bile duct cancer, also known as cholangiocarcinoma, is a rare and aggressive form of cancer that originates in the bile ducts. The bile ducts are thin tubes that carry bile, a digestive fluid produced by the liver, to the small intestine. Bile duct cancer can occur in any part of the bile duct system, from the liver to the small intestine.This type of cancer is challenging to diagnose in its early stages, often leading to late-stage detection when treatment options may be limited. The exact cause of bile duct cancer is unclear, but certain factors such as chronic inflammation of the bile ducts, bile duct stones, and certain liver diseases may increase the risk.Symptoms of bile duct cancer can include jaundice (yellowing of the skin and eyes), abdominal pain, unexplained weight loss, and itching. However, these symptoms can also be associated with other conditions, making early detection difficult.Treatment options for bile duct cancer depend on the stage of the disease and may include surgery, chemotherapy, and radiation therapy. Unfortunately, the prognosis for bile duct cancer is often poor due to its aggressive nature and late-stage diagnosis.Research and clinical trials are ongoing to improve our understanding of bile duct cancer and develop more effective treatment approaches. It is crucial for individuals at risk or experiencing symptoms to seek prompt medical attention for early detection and intervention.If you or someone you know is facing a diagnosis of bile duct cancer, consulting with healthcare professionals and specialists is essential to explore available treatment options and support services. As with any cancer diagnosis, a comprehensive and personalized approach to care is crucial for the best possible outcome.

Committee Members
Speaker at International Cancer Conference 2026 - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States
Speaker at International Cancer Conference 2026 - Patricia Tai

Patricia Tai

UpToDate, Canada
Speaker at International Cancer Conference 2026 - Jose Manuel Cervera Grau

Jose Manuel Cervera Grau

Preclinical Lab and Computational Drug Discovery Program, Relayer Biotech Inc, Spain

Submit your abstract Today

Facebook Twitter XTwitter Youtube
Watsapp